A multi-centre, randomised, double-blind trial studying the effect of misoprostol on the outcome of intra-uterine inseminatio

Not Applicable

Completed

• Conditions: Pregnancy, prostaglandin, misoprostol, vaginal suppository, Intra-Uterine Insemination (IUI); Pregnancy and Childbirth; Pregnancy

• Registration Number: ISRCTN76424181
• Lead Sponsor: niversity Hospital Ghent (Belgium)

Brief Summary

2008 Results article in https://doi.org/10.1159/000133951 (added 19/10/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2005-06-30
• Study Start: 2007-05-30
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 217

Inclusion Criteria

1. All women presenting for Intra-Uterine Insemination (IUI)
2. Between the age of 20 and 36 years
3. Bilateral tubal patency was proven
4. Total motile fraction of the semen sample was more than 1 million after preparation
5. Informed consent

Exclusion Criteria

1. History of previously failed intra-uterine insemination
2. Severe comorbidity (endometriosis, fibroma)
3. Previous allergic reactions to misoprostol

Study & Design

• Study Type: Interventional
• Study Design: Not specified